Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

13463results about "Proteomics" patented technology

Artificial intelligence-based quality scoring

The technology disclosed assigns quality scores to bases called by a neural network-based base caller by (i) quantizing classification scores of predicted base calls produced by the neural network-based base caller in response to processing training data during training, (ii) selecting a set of quantized classification scores, (iii) for each quantized classification score in the set, determining a base calling error rate by comparing its predicted base calls to corresponding ground truth base calls, (iv) determining a fit between the quantized classification scores and their base calling error rates, and (v) correlating the quality scores to the quantized classification scores based on the fit.
Owner:ILLUMINA INC

Genome-wide prediction method based on deep learning by using genome-wide data and bioinformatics features

ActiveUS20250104813A1BiostatisticsProteomics
Genome-wide data is obtained, and data cleansing, data sparsity processing and bioinformatics feature extraction are performed on the obtained genome-wide data; model construction is performed based on the sparsity-processed genome-wide data and the bioinformatics features to obtain a preliminary hybrid model; model training, regularization, and interpretability enhancement are performed on the preliminary hybrid model to obtain a trained model weight and an interpretability analysis corresponding to the trained model weight; learning and uncertainty estimation are performed based on the trained model weight and to-be-predicted genome-wide data on the hybrid model to obtain an integrated prediction result and uncertainties corresponding to the integrated prediction result; and personalized medical advice and decision assistance are performed based on the integrated prediction result, the interpretability analysis, and the uncertainties corresponding to the integrated prediction result.
Owner:INSTITUTE OF CROP SCIENCE CHINESE ACADEMY OF AGRICULTURAL SCIENCES +1

Federated Distributed Computational Graph Platform for Advanced Robotic Integration in Precision Oncological and Gene Therapies

A federated distributed computational system enables secure oncological therapy optimization through robotic integration. The system establishes a distributed graph architecture with secure communication channels connecting computational nodes, implementing encryption protocols for cross-institutional data exchange. Each node contains processing capabilities for fluorescence-guided imaging, uncertainty quantification, and expert knowledge integration while maintaining hierarchical knowledge graphs of oncological biomarkers, interventions, and outcomes. The system coordinates domain-specific knowledge through token-space communication and implements an advanced robotic integration system for surgical interventions using spatiotemporal tumor mapping, multi-modal fluorescence imaging, surgical robot coordination, and space-time stabilized mesh management. Key capabilities include wavelength-specific multi-modal fluorescence detection, combined epistemic and aleatoric uncertainty estimation, tensor-based data integration with adaptive dimensionality control, and light cone search for adaptive treatment optimization—all while maintaining strict privacy controls.
Owner:QOMPLX INC

System and methods for ai-enhanced cellular modeling and simulation

The AI-enhanced cellular modeling and simulation platform is a computational system designed to enhance biomedical research and development and personalized medicine and wellness. This platform integrates simulation modeling, machine learning and artificial intelligence, multi-omics data, and sophisticated data fusion and decision-support techniques to create comprehensive models of cellular systems and processes across multiple scales. It enables researchers and clinicians to simulate complex biological interactions, predict disease progression, and design or optimize treatment strategies or medical devices with improved accuracy and efficacy. The system's architecture allows for integration of various components, including real-time data processing, federated learning, and quantum computing enhancements. From personalized drug discovery and cancer therapies to synthetic biology and epidemiological analysis, this platform offers powerful tools for understanding and manipulating cellular systems and bioengineered systems. By bridging the gap between molecular-level interactions between cells and materials and organism-wide effects, it enables significant advancements in healthcare and biological sciences.
Owner:QOMPLX INC

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Federated Distributed Computational Graph Platform with Advanced Multi-Expert Integration and Adaptive Uncertainty Quantification for Precision Oncological Therapy

A federated distributed computational system enables secure oncological therapy optimization through multi-expert integration and advanced uncertainty quantification. The system implements a multi-expert integration framework that coordinates domain-specific knowledge through token-space communication for precision oncological treatment, while maintaining secure cross-institutional data exchange. The architecture coordinates multi-scale spatiotemporal synchronization across computational nodes, with each node containing local processing capabilities for fluorescence-guided imaging, uncertainty quantification, and expert knowledge integration. Through a distributed graph architecture, the system enables advanced fluorescence imaging with wavelength-specific targeting, multi-level uncertainty estimation combining epistemic and aleatoric approaches, and multi-scale tensor-based integration with adaptive dimensionality control. The system implements light cone search and planning for adaptive treatment strategy optimization, enabling medical institutions and research organizations to collaborate on complex oncological therapy projects while maintaining strict data privacy controls.
Owner:QOMPLX INC

Federated Distributed Computational Graph Platform for Genomic Medicine and Biological System Analysis

A federated distributed computational system enables secure, multi-institutional biological data analysis and genomic medicine through interconnected, decentralized nodes in a federated distributed graph architecture. A federation manager coordinates computational resource allocation, control and data flows, establishes privacy and security boundaries, implements multi-scale spatiotemporal analysis and simulation modeling, models cross-species or intrapopulation elements, and maintains cross-institutional knowledge relationships. Each node includes a local processing unit for biological data analysis, including multiomics and gene editing, privacy-preserving protocols for secure multi-party computation, a hierarchical knowledge graph for managing multi-domain biological relationships across spatial and temporal scales, and encrypted network connections. The system implements cross-species genetic analysis via phylogenetic integration, environmental response modeling through spatiotemporal tracking, and multi-scale tensor-based data integration with adaptive dimensionality control. This architecture enables research institutions to collaborate on complex biological analyses and genomic medicine applications while maintaining strict data privacy and security controls.
Owner:QOMPLX INC

Thyroid cancer electronic medical record system based on multi-modal data fusion

The invention relates to the field of medical informatization. The invention discloses a thyroid cancer electronic medical record system based on multi-modal data fusion. The thyroid cancer electronic medical record system comprises a multi-modal data acquisition module which acquires patient texts, ultrasonic images, genes, biochemical indexes and clinical data and performs standardized calibration to generate standard data; the multi-modal feature extraction module extracts semantic, structure, mutation, change and fluctuation features of each standard data through multiple technologies; the single-mode prediction model construction module constructs single-mode prediction models of texts, images and the like based on the features and outputs results; and the multi-modal fusion prediction module fuses the single-modal model based on the deep learning framework to output a multi-modal fusion prediction result. According to the invention, multi-modal data are integrated, and the accuracy and comprehensiveness of thyroid cancer diagnosis are improved. The system ensures consistency through standardized data processing, and assists doctors to accurately judge pathological types, recommend therapeutic schedules and evaluate prognosis by means of a multi-modal feature extraction and fusion mechanism.
Owner:ZHEJIANG CANCER HOSPITAL

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Detecting mutations and ploidy in chromosomal segments

The invention provides methods, systems, and computer readable medium for detecting ploidy of chromosome segments or entire chromosomes, for detecting single nucleotide variants and for detecting both ploidy of chromosome segments and single nucleotide variants. In some aspects, the invention provides methods, systems, and computer readable medium for detecting cancer or a chromosomal abnormality in a gestating fetus.
Owner:NATERA INC

Federated Distributed Computational Graph Platform for Oncological Therapy and Biological Systems Analysis with Neurosymbolic Deep Learning

A federated distributed computational system enables secure biological data analysis and genomic medicine through hybrid simulation capabilities. The system implements a hybrid simulation orchestrator that coordinates classical numerical simulations with machine learning models for biological system analysis, while maintaining secure cross-institutional data exchange. The architecture coordinates multi-scale spatiotemporal synchronization across computational nodes, with each node containing local processing capabilities for biological data analysis and privacy preservation protocols. The system implements cellular machinery assembly analysis, real-time patient data integration, and multi-modal image integration with spatiotemporal health data annotation. Through a distributed graph architecture, the system enables cross-species genetic analysis, environmental response modeling, and multi-scale tensor-based data integration with adaptive dimensionality control. The system implements real-time therapeutic response prediction through multi-modal data analysis, enabling research institutions to collaborate on complex biological analyses while maintaining strict data privacy controls.
Owner:QOMPLX INC

Whole course follow-up visit management system and method for gynaecology and

The invention discloses a whole course follow-up visit management system and method for gynaecology and obstetrics patients, and relates to the field of medical information management.The method comprises the steps that when a patient sees a doctor for the first time, basic information, medical related information, medical image data, gene detection data, sensor data and patient self-report data of the patient are input; preprocessing the input patient data, and integrating the preprocessed patient data into a personal health record; establishing a health assessment model of the patient based on the integrated personal health record, outputting a current health assessment score of the patient, and generating a follow-up visit plan according to the current health assessment score of the patient; and establishing an obstetrical complication prediction model based on the personal health record, and outputting a patient complication prediction value. Potential obstetrical complication risks are recognized in advance, especially when the health condition of the pregnant and lying-in woman changes, the prediction result can be dynamically updated, real-time monitoring and early warning of complication are achieved, and safety management of the lying-in woman is optimized.
Owner:JILIN UNIV FIRST HOSPITAL

Benign and malignant nodule grading evaluation system based on large model fusion ultrasonic imaging and thyroid gene marker

PendingCN120452757AImage analysisHealth-index calculationMalignancyGold standard (test)
The invention discloses a benign and malignant nodule grading evaluation system based on large model fusion ultrasonic imaging and thyroid gene markers, which can organically fuse non-invasive examination and serological detection, can simulate and diagnose multi-grade risk probability information provided by a gold standard, realizes similar risk grading estimation in a non-invasive mode, and has a wide application prospect. The thyroid nodule risk assessment method can provide visual explanation conforming to clinical logic based on comprehensive information of iconography and molecular biology, can significantly improve the accuracy of thyroid nodule risk assessment, can also effectively improve clinical decision-making efficiency and patient credibility, and has important clinical application prospects. The system comprises a data acquisition module, an ultrasonic image feature extraction module, a gene marker feature extraction module, a multi-modal fusion and hierarchical reasoning module and a generation module.
Owner:THE FIRST AFFILIATED HOSPITAL OF MEDICAL COLLEGE OF XIAN JIAOTONG UNIV

Genomics-based Parkinson's disease drug target prediction model construction method

The invention discloses a genomics-based Parkinson's disease drug target prediction model construction method, and relates to the technical field of drug research and development, and the method comprises the following steps: collecting genomics, transcriptomics and proteomics data related to Parkinson's disease patients, and carrying out quality control and standardization processing; through differential expression analysis and function enrichment, key genes and signal pathways related to Parkinson's disease are identified, and a potential drug target range is determined. By integrating genomics, transcriptomics and proteomics data of patients with Parkinson's disease, molecular mechanisms related to Parkinson's disease can be comprehensively analyzed, multi-target combination is optimized in combination with the ant colony algorithm, the limitation that a traditional single-target model is difficult to capture complex disease network comprehensiveness is effectively overcome, and the method is suitable for popularization and application. The accuracy of target spot prediction is remarkably improved, a more reliable action target spot is provided for drug research and development, and the failure rate of clinical tests is reduced.
Owner:DALIAN MEDICAL UNIVERSITY

Rape seed quality evaluation model based on big data

The invention relates to the technical field of seed processing analysis, in particular to a big data-based rape seed quality evaluation model, which is characterized in that a data pool is constructed by converging multi-source heterogeneous rape data, and high-quality input is provided for subsequent cross-domain feature association; a cross-domain feature interaction graph is constructed, a graph neural network is used for learning, cross-domain feature interaction is visually presented, and a gene-environment interaction relationship is analyzed; through a four-branch multi-head and cross-modal attention analysis atlas, focusing key features, fusing optimization information and generating a high-quality feature vector, high-order feature nonlinear fusion is realized, and the characterization capability of the model on multi-source heterogeneous data is remarkably improved; an evaluation model is constructed through decoding vectors, and high-yield variety data is extracted, so that efficient screening of rape varieties is facilitated; by deploying the generative adversarial network and transferring the learning adaptive model, the evaluation capability is quickly expanded to a new variety, and breeding intelligence is promoted.
Owner:BEIJING MAIMAI QUGENG TECH CO LTD

Sheep single nucleotide polymorphism (SNP) molecular marker and use thereof in detecting resistance to brucellosis in sheep

A sheep single nucleotide polymorphism (SNP) molecular marker and use thereof in detecting resistance to brucellosis in sheep are provided, relating to the technical field of molecular marker-assisted breeding. A sheep SNP molecular marker is provided, where the sheep SNP molecular marker is associated with resistance to brucellosis in sheep, and has a nucleotide sequence shown in SEQ ID NO: 1 in which a T / C polymorphism is located at 101st bp. The sheep SNP molecular marker can accurately detect a resistance level of sheep to the brucellosis, and is used for the selection of brucellosis-resistant sheep as well as molecular marker-assisted breeding of the resistance to brucellosis in sheep. The sheep SNP molecular marker effectively improves a breeding efficiency of sheep with brucellosis resistance.
Owner:INST OF ANIMAL SCI OF CAAS

Intelligent breeding planning and decision-making method and system based on large model

The invention relates to the technical field of breeding planning, in particular to an intelligent breeding planning and decision-making method and system based on a large model. The method comprises the following steps: acquiring a multi-source breeding data set; constructing a structured breeding knowledge graph based on the multi-source breeding data set; performing breeding data association on the structured breeding knowledge graph according to a preset large model to generate a special breeding basic model; obtaining a breeding instruction input by a user; performing user semantic recognition on a breeding instruction input by a user to generate breeding semantic recognition data; inputting the breeding semantic recognition data into a breeding special basic model for breeding intention analysis, and generating user breeding intention data; and determining data information needing to be called based on the breeding intention data of the user, analyzing and screening to generate germplasm resource screening data and a breeding plan / breeding decision scheme. According to the method, the intelligence and operability of breeding planning are improved through integration of multi-source data, intelligent semantic recognition, combined genetic analysis and executable evaluation.
Owner:CHANGSHA BAIAOYUN DATA TECH CO LTD +1

Virtual transcriptomics

Atherosclerotic plaque phenotyping by image data analysis, e.g., using conventional computed tomography angiography (CTA) or other imaging modalities can elucidate the molecular signature of atherosclerotic lesions on a per-patient basis. The present disclosure relates to methods of atherosclerotic plaque phenotyping to provide a subject-specific predictive model for gene expression referred to as virtual transcriptomics.
Owner:ELUCID BIOIMAGING INC

Data processing method and system for multi-source complex biological information data

InactiveCN120148619ABiostatisticsProteomicsGenes mutationCox proportional hazards regression
The invention relates to a data processing method and system for multi-source complex biological information data. According to the method, expression profile data, gene variation data and clinical survival data are collected, and unified standardization processing is carried out on the collected data. Feature alignment is performed on different source data based on sample identifiers, a joint feature expression matrix is constructed, and a context dependency relationship across data types is maintained. On the basis, multi-stage feature screening is carried out through Lasso regression and information gain evaluation in sequence, and an optimal feature subset used for modeling is obtained. And further training a risk scoring model by adopting a Cox proportional risk regression method, and calculating a risk scoring value of the sample by utilizing the constructed continuous scoring function. And finally, dividing the score value into a plurality of risk levels, and generating a survival curve of each level in combination with a Kaplan-Meier estimation method so as to verify the risk layering effect and prediction significance of the model. According to the method, the accuracy of biological information modeling can be improved, and the method has good universality and practical value.
Owner:KARAMAY CENT HOSPITAL

Neural network prediction method for intestinal cancer immune response map, medium and equipment

The invention discloses an intestinal cancer immune response graph neural network prediction method, a medium and equipment, and the method comprises the steps: collecting pathological image information, immunodetection information and basic clinical information, extracting a tissue space distribution characteristic spectrum through a deep convolutional network, and constructing a graph neural network model in combination with an immunomarker expression characteristic matrix; spatial interaction characteristics of a tumor microenvironment are modeled by adopting a graph attention mechanism, finally a treatment response probability, an optimal treatment opportunity and an adverse reaction risk are predicted through a multi-task learning framework, and a clinical decision report containing a prediction response curve, a risk early warning threshold and a treatment time window suggestion is output. According to the method, through multi-modal data fusion and spatial interaction modeling, accurate prediction of intestinal cancer immunotherapy response is realized, and a more comprehensive reference basis is provided for clinical decision making.
Owner:FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE

Apparatus and method for training a tunable data structure to predict internal ribosome entry site (IRES) activity

An apparatus for training a tunable data structure to predict internal ribosome entry site (IRES) activity includes at least a processor and a memory containing instructions configuring the at least a processor to assemble a training set including a plurality of nucleotide sequence data examples IRES sequences and a plurality of correlated observed IRES activity, partition the training set into at least a first section and a second section, train, using the first section at least an activity data structure to generate probable IRES activity using nucleotide sequence data, and iteratively retrain the at least an activity data structure using the second section, wherein each iteration of the iterative retraining includes generating a predicted IRES activity value using the at least an activity neural network and a nucleotide sequence data example, evaluating an error function, and tuning the activity data structure.
Owner:ORNA THERAPEUTICS INC

Virtual transcriptomics

Atherosclerotic plaque phenotyping by image data analysis, e.g., using conventional computed tomography angiography (CTA) or other imaging modalities can elucidate the molecular signature of atherosclerotic lesions on a per-patient basis. The present disclosure relates to methods of atherosclerotic plaque phenotyping to provide a subject-specific predictive model for gene expression referred to as virtual transcriptomics.
Owner:ELUCID BIOIMAGING INC

Construction method and system for reproductive medicine database

The invention relates to the technical field of database construction, in particular to a construction method and system for a reproductive medicine database. The method comprises the following steps: acquiring a biological tissue sample of a patient; acquiring reproductive endocrine hormone data, embryo morphological parameter data, immune cell function data and genome variation data from the biological tissue sample of the patient; performing time sequence analysis processing on the hormone fluctuation mode according to the reproductive endocrine hormone data to obtain endocrine dynamic characteristic data; performing image recognition processing based on coherent superposition characteristics of light on the embryo morphological parameter data, and performing embryo development potential evaluation to obtain embryo development potential data; and performing hierarchical clustering processing on the individual heterogeneity of the patient according to the immune cell function data and the genome variation data to obtain immune-genetic typing data of the patient. By means of the quantum dot sensing technology and the multi-channel micro-fluidic chip, standardization of data acquisition is achieved, and the heterogeneity problem of a data source is solved.
Owner:HUNAN FURUI BIOPHARMA TECH CO LTD

Multi-fusion seaweed field ecosystem observation method, system, equipment and medium

The invention provides a multi-fusion seaweed field ecosystem observation method, system, device and medium, and belongs to the technical field of ecological monitoring, the method comprises the following steps: obtaining chlorophyll a concentration, seaweed canopy spectrum and three-dimensional biomass point cloud; aligning the chlorophyll a concentration of the target sea area with the seaweed canopy spectrum, and fusing the three-dimensional biomass point cloud to generate a three-dimensional biomass model; constructing an in-situ sampling network to monitor water quality parameters, benthic organism video streams and eDNA metagenome sequencing data, calibrating a three-dimensional biomass model, executing anomaly detection through a lightweight LSTM model, and identifying benthic organism species in real time through an improved YOLOv5 model; constructing a graph neural network, outputting a carbon sink prediction value, generating a brown tide early warning signal when the carbon sink prediction value is lower than a dynamic threshold value, optimizing a patrol path of the unmanned aerial vehicle based on reinforcement learning, and improving the sampling frequency of the water quality sensor. According to the invention, multi-fusion monitoring of the seaweed field is realized, the ecological condition is accurately evaluated, and abnormity is warned in advance.
Owner:STATE OCEANIC ADMINISTRATION YANTAI MARINE ENVIRONMENT MONITORING CENT STATION

Source of origin deconvolution based on methylation fragments in cell-free DNA samples

A method and system for determining one or more sources of a cell free deoxyribonucleic acid (cfDNA) test sample from a test subject. The cfDNA test sample contains a plurality of deoxyribonucleic acid (DNA) molecules with numerous CpG sites that may be methylated or unmethylated. A trained deconvolution model comprises a plurality of methylation parameters, including a methylation level at each CpG site for each source, and a function relating a sample vector as input and a source of origin prediction as output. The method generates a test sample vector comprising a site methylation metric relating to DNA molecules from the test sample that are methylated at that CpG site. The method inputs the test sample vector into the trained deconvolution model to generate a source of origin prediction indicating a predicted DNA molecule contribution of each source.
Owner:GRAIL INC

Gene detection data cleaning method and system based on artificial intelligence

The invention relates to the technical field of genomics, in particular to a gene detection data cleaning method and system based on artificial intelligence. The method comprises the following steps: acquiring gene detection data, and performing preliminary filtering on the gene detection data based on removal of low-quality reads to obtain preliminary filtering data; performing linker sequence identification and removal on the preliminarily filtered data, and performing sequencing error correction to generate gene sequence data; performing GC content analysis and repetitive sequence identification on the gene sequence data to obtain sequence feature data; performing dynamic quality threshold adjustment according to the sequence feature data, and performing secondary filtering on the gene sequence data to generate high-quality sequence data; and performing sequence pattern recognition on the high-quality sequence data to obtain sequence pattern feature data. According to the method, deep analysis is carried out by utilizing sequence characteristics such as GC content and nucleotide distribution, and the recognition capability on sequence complexity and variation modes is improved.
Owner:SICHUAN BAIYUE BIOTECHNOLOGY CO LTD

Soil groundwater pollution fine investigation method

The invention relates to the technical field of water source pollution investigation, and particularly discloses a soil groundwater pollution fine investigation method which comprises the steps of S1, pollution source investigation, S2, sampling design, S3, laboratory analysis, S4, ecological risk assessment, S5, restoration suggestion and S6, dynamic monitoring. According to the invention, through machine learning and big data analysis, historical pollution data, field sampling data and spatial geographic information can be effectively integrated to form an accurate pollution source distribution map, which not only facilitates identification of pollution hot spot areas, but also can predict the pollutant diffusion trend through a data-driven model to provide dynamic prediction of future pollution evolution; according to the method, high-precision positioning of a complex pollution area is realized, blind sampling and invalid investigation are reduced, the resource utilization efficiency is improved, the area where pollutants are possibly diffused in the future can be predicted, prevention and control measures are taken in advance, and further environmental damage is avoided.
Owner:GEOLOGICAL INFORMATION EXPLORATION BRANCH OF SINOPEC PETROLEUM ENG GEOPHYSICS CO LTD